Comment on CMS-2026-1256-0002
GlytecSupportAdvocacy
Summary: Glytec, a technology-enabled clinical decision support company, supports CMS's proposal to adopt the "Diabetes Excess Days in Acute Care (EDAC)" measure to improve inpatient diabetes management. The company argues that the measure will incentivize hospitals to adopt evidence-based digital health solutions to reduce preventable readmissions and improve patient safety.
On behalf of Glytec, thank you for the opportunity to comment on the Centers for Medicare and Medicaid Services’ (CMS) Fiscal Year (FY) 2027 Inpatient Prospective Payment System (IPPS) Proposed Rule, which includes policy and technical changes to the Inpatient Quality Reporting (IQR) program. Please see the attached file for our full comment submission.